Mackenzie Financial
CLVS

Mackenzie Financial’s Clovis Oncology, Inc. CLVS Stock Holding History

Mackenzie Financial’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-78,777
Closed -$351K – 1528
2021
Q3 		$351K Buy
78,777
+2,468
+3% +$11.9K ﹤0.01% 1079
2021
Q2 		$443K Buy
76,309
+33,309
+77% +$195K ﹤0.01% 1004
2021
Q1 		$302K Buy
+43,000
New +$288K ﹤0.01% 1013
2020
Q3 		– Sell
-98,580
Closed -$665K – 1073
2020
Q2 		$665K Buy
+98,580
New +$746K ﹤0.01% 751

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mackenzie Financial's CLVS Position: Q4 2021 in Review

Mackenzie Financial sold out of Clovis Oncology, Inc. (CLVS) in Q4 2021, closing a stake of 78,777 shares — an estimated $351K sold.

Mackenzie Financial first reported a position in CLVS in Q2 2020 and held it in 4 quarters. The position peaked at $665K in Q2 2020. 153 funds tracked by Wall St. Rank hold CLVS as of Q4 2021.

  • Mackenzie Financial reported no remaining Clovis Oncology, Inc. position as of Q4 2021 after selling out during the quarter.
  • Mackenzie Financial sold 78,777 Clovis Oncology, Inc. shares in Q4 2021, an estimated $351K.
  • Mackenzie Financial first reported a position in Clovis Oncology, Inc. in Q2 2020 and held it in 4 quarters.
  • Mackenzie Financial's Clovis Oncology, Inc. position peaked at $665K in Q2 2020.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2021.

Based on Mackenzie Financial's 13F filing for Q4 2021, filed 14 Feb 2022.